A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon®).

By ganirelix dose-finding study group The  

Human Reproduction, Vol. 13, Iss. 11, 1998-11 ,pp. : 3023-3031

Oxford University Press

Access to resources Recommend Favorite

Detecting pre-ovulatory luteinizing hormone surges in urine

By Kesner JS  

Human Reproduction, Vol. 13, Iss. 1, 1998-01 ,pp. : 15-21

Oxford University Press

Access to resources Recommend Favorite

Recombinant luteinizing hormone priming in multiple follicular stimulation for in-vitro fertilization in downregulated patients

By Lisi F.   Caserta D.   Montanino M.   Berlinghieri V.   Bielli W.   Carfagna P.   Carra M.C.   Costantino A.   Lisi R.   Poverini R.   Ciardo F.   Rago R.   Marci R.   Moscarini M.  

Gynecological Endocrinology, Vol. 28, Iss. 9, 2012-09 ,pp. : 674-677

Informa Healthcare

Access to resources Recommend Favorite

Peripheral Patterns of Growth Hormone, Luteinizing Hormone, and Progesterone Before, at, and after Puberty in Buffalo Heifer

By Haldar A.   Prakash B. S.  

Endocrine Research, Vol. 31, Iss. 4, 2005-10 ,pp. : 295-306

Informa Healthcare

Access to resources Recommend Favorite

Luteinizing hormone response to gonadotrophin-releasing hormone in normal women undergoing ovulation induction with urinary or recombinant follicle stimulating hormone

By Messinis IE  

Human Reproduction, Vol. 13, Iss. 9, 1998-09 ,pp. : 2415-2420

Oxford University Press

Access to resources Recommend Favorite